Related Experiment Video

Updated: Jul 6, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Pediatric celiac disease

Mary-Alice Tully1

  • 1Gastroenterology and Nutrition, Children's Hospital Boston, 300 Longwood Avenue, Hunnewell Ground, Boston, MA 02115, USA. maryalice.tully@childrens.harvard.edu

Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|April 9, 2008
PubMed

Insights

Celiac disease, an immune response to gluten damaging the small intestine, affects 1 in 100 children. Early diagnosis and a lifelong gluten-free diet are crucial for managing this condition.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Nutrition Science

Background:

  • Celiac disease is an autoimmune disorder triggered by gluten ingestion.
  • It leads to villous atrophy and malabsorption in the small intestine.
  • The condition is more common and presents more subtly than previously thought, affecting approximately 1 in 100 children in the U.S.

Purpose of the Study:

  • To highlight the prevalence and varied presentations of celiac disease in children.
  • To outline diagnostic pathways for suspected cases.
  • To emphasize the importance of dietary management and support systems.

Main Methods:

  • Review of celiac disease presentation and diagnosis in pediatric populations.
  • Discussion of serologic testing and endoscopic biopsy procedures.
  • Emphasis on lifelong gluten-free diet adherence and multidisciplinary support.

Main Results:

  • Celiac disease prevalence in U.S. children is estimated at 1 in 100.
  • Children may present with overt symptoms (failure to thrive, diarrhea) or subtle signs like constipation.
  • Asymptomatic cases also occur, necessitating screening in high-risk individuals.

Conclusions:

  • Early diagnosis through serologic testing and biopsy is vital.
  • Lifelong gluten-free diet is the primary treatment.
  • Comprehensive family education, including dietician consultation and support groups, is essential for successful management.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...